Creatinine Measurement - Global Market Outlook (2017-2026)

November 2018 | 201 pages | ID: CC3A01E051BEN
Stratistics Market Research Consulting

Abstracts

According to Stratistics MRC, the Global Creatinine Measurement Market is accounted for $330.90 million in 2017 and is expected to reach $745.00 million by 2026 growing at a CAGR of 9.4% during the forecast period. The growing renal functioning disorder and increasing geriatric population are driving the market. However, often changing regulatory policies and recognition of novel renal dysfunction biomarkers are hampering the market growth. Moreover, commercialization of sophisticated testing methods is providing ample opportunity for the growth of the market.

Creatinine measurement is the process of measuring creatinine. Creatinine is a waste product that is obtained from the human body due to the general breakdown of muscle tissues. The creatinine produced in the body is then filtered using kidneys. The basic kidney test carried out is analyzed using the creatinine levels in the blood.

Based on the sample, blood/ serum segment is attributed to observe ample growth opportunities, as most of the creatinine measurement kits and reagents are based on the analysis of creatinine in blood samples due to its accurateness in inferring creatinine concentration and less menace of contamination. These benefits are liable for the growing acceptance of the blood/serum sample for the measurement of creatinine levels.

By geography, North America acquired largest market share owing to the factors such as rising occurrence of renal disorders, increasing the prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction) in the region and the implementation of favorable management initiatives to raise awareness about kidney diseases and their untimely diagnosis.

Some of the key players profiled in the Creatinine Measurement market include Siemens Healthineers, Abbott Laboratories (US), Diazyme Laboratories, Inc., Wako Pure Chemical Industries Ltd., Randox Laboratories, Danaher Corporation (US), Pointe Scientific, Thermo Fisher Scientific Inc, Ortho-Clinical Diagnostics, F. Hoffmann-la Roche Ltd (Switzerland), Roche, Dialab GmbH (Vienna), Sentinel Ch. Spa. (Italy) and Diasys Diagnostic Systems GmbH (Germany).

Types Covered:

• Jaffe’S Kinetic Method
• Enzymatic Method

Products Covered:

• Kits
• Reagents

Samples Covered:

• Blood/Serum
• Urine

End Users Covered:

• Diagnostic Laboratories
• Hospitals

Regions Covered:

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• UK
• Italy
• France
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• New Zealand
• South Korea
• Rest of Asia Pacific
• South America
• Argentina
• Brazil
• Chile
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• UAE
• Qatar
• South Africa
• Rest of Middle East & Africa

WHAT OUR REPORT OFFERS:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 9 years of all the mentioned segments, and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
  2.4.1 Data Mining
  2.4.2 Data Analysis
  2.4.3 Data Validation
  2.4.4 Research Approach
2.5 Research Sources
  2.5.1 Primary Research Sources
  2.5.2 Secondary Research Sources
  2.5.3 Assumptions

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 GLOBAL CREATININE MEASUREMENT MARKET, BY TYPE

5.1 Introduction
5.2 Jaffe’S Kinetic Method
5.3 Enzymatic Method

6 GLOBAL CREATININE MEASUREMENT MARKET, BY PRODUCT

6.1 Introduction
6.2 Kits
6.3 Reagents

7 GLOBAL CREATININE MEASUREMENT MARKET, BY SAMPLE

7.1 Introduction
7.2 Blood/Serum
7.3 Urine

8 GLOBAL CREATININE MEASUREMENT MARKET, BY END USER

8.1 Introduction
8.2 Diagnostic Laboratories
8.3 Hospitals

9 GLOBAL CREATININE MEASUREMENT MARKET, BY GEOGRAPHY

9.1 Introduction
9.2 North America
  9.2.1 US
  9.2.2 Canada
  9.2.3 Mexico
9.3 Europe
  9.3.1 Germany
  9.3.2 UK
  9.3.3 Italy
  9.3.4 France
  9.3.5 Spain
  9.3.6 Rest of Europe
9.4 Asia Pacific
  9.4.1 Japan
  9.4.2 China
  9.4.3 India
  9.4.4 Australia
  9.4.5 New Zealand
  9.4.6 South Korea
  9.4.7 Rest of Asia Pacific
9.5 South America
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America
9.6 Middle East & Africa
  9.6.1 Saudi Arabia
  9.6.2 UAE
  9.6.3 Qatar
  9.6.4 South Africa
  9.6.5 Rest of Middle East & Africa

10 KEY DEVELOPMENTS

10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 COMPANY PROFILING

11.1 Siemens Healthineers
11.2 Abbott Laboratories (US)
11.3 Diazyme Laboratories, Inc.
11.4 Wako Pure Chemical Industries Ltd.
11.5 Randox Laboratories
11.6 Danaher Corporation (US)
11.7 Pointe Scientific
11.8 Thermo Fisher Scientific Inc
11.9 Ortho Clinical Diagnostics
11.10 F. Hoffmann-la Roche Ltd (Switzerland)
11.11 Roche
11.12 Dialab GmbH (Vienna)
11.13 Sentinel Ch. Spa. (Italy)
11.14 Diasys Diagnostic Systems GmbH (Germany)

List Of Tables

LIST OF TABLES

Table 1 Global Creatinine Measurement Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 4 Global Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 5 Global Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 6 Global Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 7 Global Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 8 Global Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 9 Global Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 10 Global Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 11 Global Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 12 Global Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 13 Global Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN)
Table 14 North America Creatinine Measurement Market Outlook, By Country (2016-2026) ($MN)
Table 15 North America Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 16 North America Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 17 North America Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 18 North America Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 19 North America Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 20 North America Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 21 North America Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 22 North America Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 23 North America Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 24 North America Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 25 North America Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 26 North America Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN)
Table 27 Europe Creatinine Measurement Market Outlook, By Country (2016-2026) ($MN)
Table 28 Europe Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 29 Europe Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 30 Europe Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 31 Europe Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 32 Europe Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 33 Europe Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 34 Europe Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 35 Europe Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 36 Europe Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 37 Europe Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 38 Europe Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 39 Europe Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN)
Table 40 Asia Pacific Creatinine Measurement Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 42 Asia Pacific Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 43 Asia Pacific Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 44 Asia Pacific Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 45 Asia Pacific Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 46 Asia Pacific Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 47 Asia Pacific Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 48 Asia Pacific Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 49 Asia Pacific Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 50 Asia Pacific Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 51 Asia Pacific Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 52 Asia Pacific Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN)
Table 53 South America Creatinine Measurement Market Outlook, By Country (2016-2026) ($MN)
Table 54 South America Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 55 South America Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 56 South America Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 57 South America Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 58 South America Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 59 South America Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 60 South America Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 61 South America Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 62 South America Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 63 South America Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 64 South America Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 65 South America Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN)
Table 66 Middle East & Africa Creatinine Measurement Market Outlook, By Country (2016-2026) ($MN)
Table 67 Middle East & Africa Creatinine Measurement Market Outlook, By Type (2016-2026) ($MN)
Table 68 Middle East & Africa Creatinine Measurement Market Outlook, By Jaffe’S Kinetic Method (2016-2026) ($MN)
Table 69 Middle East & Africa Creatinine Measurement Market Outlook, By Enzymatic Method (2016-2026) ($MN)
Table 70 Middle East & Africa Creatinine Measurement Market Outlook, By Product (2016-2026) ($MN)
Table 71 Middle East & Africa Creatinine Measurement Market Outlook, By Kits (2016-2026) ($MN)
Table 72 Middle East & Africa Creatinine Measurement Market Outlook, By Reagents (2016-2026) ($MN)
Table 73 Middle East & Africa Creatinine Measurement Market Outlook, By Sample (2016-2026) ($MN)
Table 74 Middle East & Africa Creatinine Measurement Market Outlook, By Blood/Serum (2016-2026) ($MN)
Table 75 Middle East & Africa Creatinine Measurement Market Outlook, By Urine (2016-2026) ($MN)
Table 76 Middle East & Africa Creatinine Measurement Market Outlook, By End User (2016-2026) ($MN)
Table 77 Middle East & Africa Creatinine Measurement Market Outlook, By Diagnostic Laboratories (2016-2026) ($MN)
Table 78 Middle East & Africa Creatinine Measurement Market Outlook, By Hospitals (2016-2026) ($MN